Work

2013 Antiviral Activity, Pharmacokinetics and Safety of Idx184 in Combination With Pegylated Interferon (pegifn) and Ribavirin (rbv) in Treatment-naive Hcv Genotype 1-infected Subjects

Year: 2010

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(10)61204-4

Authors: J. Lalezari, F. Poordad, P. Mehra, T. Nguyen, E. Dejesus, E. Godofsky, G. Dubuc Patrick, J. Chen, K. Pietropaolo, X.-J. Zhou, J.Z. Sullivan-Bólyai, D. Mayers

Institutions: Quest Clinical Research (United States), Cedars-Sinai Medical Center, Orlando Immunology Center, Bach & Godofsky Infectious Diseases

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1978160128

FWCI: 2.604

Cites:

Cited by: 22

Related to: 10